ALKS FY 2025 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.5B-5.2% YoY

Gross Profit

$1.3B86.3% margin

Operating Income

$254M17.2% margin

Net Income

$242M16.4% margin

EPS (Diluted)

$1.43

Cash Flow

Operating Cash Flow

$521M

Free Cash Flow

$480M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$668M

Stockholders' Equity

$1.8B

Cash & Equivalents

$588M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.6B	-5.2%
Gross Profit	$1.3B	$1.3B	-2.9%
Operating Income	$254M	$421M	-39.6%
Net Income	$242M	$367M	-34.2%